icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
June 22-26 2022
Back grey_arrow_rt.gif
 
 
 
Changing HCV patient profiles: insights from a large multinational real-world sofosbuvir/velpatasvir (SOF/VEL) dataset - in order to achieve HCV Elimination with Focused Treatment Approaches
 
 
  EASL 2022 June 22-26 London
 
A Mangia,1 S Fagiuoli,2 V Di Marco,3 S Shafran,4 M Khalili,5 S Milligan,6 G Papatheodoridis,7 D Ouzan,8 S Rosati,9 A Ramji,10 E Teti,11 M Garcia-Retortillo,12 F Andres Perez Hernandez,13 A Wong,14 C Fraser,15 S Rodriguez-Tajes,16 E Jimenez Mutiloa,17 LE Morano Amado,18 J O'Loan,19 F Campanale,20 G Macedo,21 M Milella,22 C Brixko,23 M Buti,24 MF Guerra Veloz,25 R Ranieri,26 S Borgia,27 A Bascia,1 CM Fernandez Rodriguez,28 B Conway,29 V de Ledinghen,30 M Fenech,31 P Ryan,32 I Maida,33 A Martins,34 S Scherbakovsky,35 I Ntalla,36 C Hernandez,37 K Vanstraelen,37 J Turnes38

0622221

0622222

0622223

0622224

0622225

0622226

0622227